StockData
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. (CMMB) stock

CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 5/30
$1.55−0.09 (-5.49%)

Close on Nov 18, 2026Market cap $11.15MP/E 1.1Yield –

Chemomab Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Chemomab Therapeutics's pe ratio was 0.9× on Nov 11, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.3× to 12.8×, with a median of 1.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×+0.4
2025Dec 31, 20250.5×−0.3
2024Dec 31, 20240.9×+0.5
2023Dec 29, 20230.4×−2.1
2022Dec 30, 20222.5×−10.3
2021Dec 31, 202112.8×+9.5
2020Jan 31, 20203.3×−0.3
2019Dec 31, 20193.6×–

More Chemomab Therapeutics figures

See a number that looks wrong?